Spinocerebellar ataxia 27B: A novel, frequent and potentially treatable ataxia
Authors:
Open Access
- 27 January 2024
- journal article
- review article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 14 (1) , e1504
Abstract
Hereditary ataxias, especially when presenting sporadically in adulthood, present a particular diagnostic challenge owing to their great clinical and genetic heterogeneity. Currently, up to 75% of such patients remain without a genetic diagnosis. In an era of emerging disease‐modifying gene‐stratified therapies, the identification of causative alleles has become increasingly important. Over the past few years, the implementation of advanced bioinformatics tools and long‐read sequencing has allowed the identification of a number of novel repeat expansion disorders, such as the recently described spinocerebellar ataxia 27B (SCA27B) caused by a (GAA)•(TTC) repeat expansion in intron 1 of the fibroblast growth factor 14 (FGF14) gene. SCA27B is rapidly gaining recognition as one of the most common forms of adult‐onset hereditary ataxia, with several studies showing that it accounts for a substantial number (9–61%) of previously undiagnosed cases from different cohorts. First natural history studies and multiple reports have already outlined the progression and core phenotype of this novel disease, which consists of a late‐onset slowly progressive pan‐cerebellar syndrome that is frequently associated with cerebellar oculomotor signs, such as downbeat nystagmus, and episodic symptoms. Furthermore, preliminary studies in patients with SCA27B have shown promising symptomatic benefits of 4‐aminopyridine, an already marketed drug. This review describes the current knowledge of the genetic and molecular basis, epidemiology, clinical features and prospective treatment strategies in SCA27B.Keywords
Funding Information
- Else Kröner-Fresenius-Stiftung
- Deutsche Forschungsgemeinschaft (441409627)
- National Institute of Neurological Disorders and Stroke (2R01NS072248‐11A1)
- Wellcome Trust
- Medical Research Council
- UCLH Biomedical Research Centre
This publication has 103 references indexed in Scilit:
- Ecology of the Aging Human BrainArchives of Neurology, 2011
- A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxiasNeurology, 2011
- The Therapeutic Mode of Action of 4-Aminopyridine in Cerebellar AtaxiaThe Journal of Neuroscience, 2010
- FGF14 regulates the intrinsic excitability of cerebellar Purkinje neuronsNeurobiology of Disease, 2009
- Long intronic GAA•TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxiaNucleic Acids Research, 2008
- Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxiaNucleic Acids Research, 2007
- Radiological characterization of spinocerebellar ataxia type 6British Journal of Radiology, 2005
- Mutation analysis in the fibroblast growth factor 14 gene: frameshift mutation and polymorphisms in patients with inherited ataxiasEuropean Journal of Human Genetics, 2004
- Population based study of late onset cerebellar ataxia in south east WalesJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Hereditary ataxias and paraplegias in Valle ďAosta, Italy: a study of prevalence and disabilityActa Neurologica Scandinavica, 1995